Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Cognitive-Prefrail Syndrome and Its Association With Adverse Health Outcomes: Results From the NuAge Observational Population-based Study

NCT04240028 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT04240028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Cognitive-Prefrail Syndrome and Its Association With Adverse Health Outcomes: Results From the NuAge Observational Population-based Study
Lead sponsor
Jewish General Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 21, 2020
Completion date
February 1, 2025
Enrollment
1,741 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive-prefrailty, motoric cognitive risk syndrome, prefrailty